subscribeSubscribe
Avadel Pharmaceuticals Announces Data Supporting Clinical Profile for LUMRYZ

Avadel Pharmaceuticals Announces Data Supporting Clinical Profile for LUMRYZ
GLOBENEWSWIRE
20 Oct 2023
Share Share
Avadel launches quick start to narcolepsy drug’s marketing

Avadel launches quick start to narcolepsy drug’s marketing
Beth Snyder Bulik ENDPTS
10 Jul 2023
Share Share
Amneal Launches Authorized Generic for Xyrem

Amneal Launches Authorized Generic for Xyrem
BUSINESSWIRE
03 Jul 2023
Share Share
FDA faces lawsuit from Jazz after approval of Avadel`s sleep aid

FDA faces lawsuit from Jazz after approval of Avadel`s sleep aid
Kevin Dunleavy FIERCE PHARMA
24 Jun 2023
Share Share
Avadel to Host Commercial Day on June 29 for LUMRYZ (sodium oxybate)

Avadel to Host Commercial Day on June 29 for LUMRYZ (sodium oxybate)
GLOBENEWSWIRE
22 Jun 2023
Share Share
D&A Pharma : Despite the latest alarming figures on alcohol dependence

D&A Pharma : Despite the latest alarming figures on alcohol dependence
PR NEWSWIRE
22 Jun 2023
Share Share
Avadel Pharmaceuticals Announces U.S. Commercial Launch of LUMRYZ

Avadel Pharmaceuticals Announces U.S. Commercial Launch of LUMRYZ
GLOBENEWSWIRE
05 Jun 2023
Share Share
FDA endorses Avadel`s Lumryz, a major threat to Jazz`s Xyrem

FDA endorses Avadel`s Lumryz, a major threat to Jazz`s Xyrem
Beth Snyder Bulik ENDPTS
03 May 2023
Share Share
Avadel Pharmaceuticals Lumryz (sodium oxybate) Receives Approval in the U.S

Avadel Pharmaceuticals Lumryz (sodium oxybate) Receives Approval in the U.S
FDA
01 May 2023
Share Share
Avadel Announces Final FDA Approval of sodium oxybate

Avadel Announces Final FDA Approval of sodium oxybate
GLOBENEWSWIRE
01 May 2023
Share Share